Aloe vera gel, hyaluronic acid, and honey form a mucoadhesive film on the esophageal mucosa to reduce inflammation.
Oral dissolvable alginate film provides consistent naloxone plasma concentrations, resolving low bioavailability in needle-free overdose treatments.
Covalent geminal diamine bonds stabilize aptamer-toxin complexes against dissociation, ensuring selective cancer cell targeting and reduced systemic toxicity.
Separable polygonal patch segments in a backing layer allow precise lesion coverage without wasting adhesive.
Pyridinone dicarboxamide compounds selectively inhibit BD2 of BET proteins, resolving the trade-off between broad activity and specific therapeutic outcomes.
Combining conjugated linoleic acid with cyclopropenoid fatty acids converts harmful carcass fat effects into beneficial quality improvements.
Clofazimine synergizes with tyrosine kinase inhibitors to nearly obliterate quiescent leukemia stem cells that resist standard therapy.
Compound A targets EP4 receptors to treat chronic renal failure while minimizing side effects on other EP subtypes.
Water dispersible enalapril minitablets enable precise pediatric dosing through rapid disintegration and uniform suspension in liquid.
Thienopyridine compounds inhibit HIF prolyl hydroxylases, stabilizing HIF levels to treat ischemia and anemia.
Laminin receptor precursor mediates dopamine synthesis, reducing levodopa dosage and minimizing dyskinesia side effects.
A lithium hydroxide and carbon dioxide dissolution process preserves molecular weight and oxidation state, overcoming harsh traditional solvent degradation.
Blocking the CCL7/CCR3 axis prevents tumor spread outside the prostatic capsule.
Porous calcium carbonate reversibly absorbs nicotine to stabilize active ingredients and prevent unfavorable interactions between formulation components.
A cyclic amine derivative provides strong analgesic action through specific stereochemical configurations.
Verbascoside restores nephrin and synaptopodin expression in glomerular podocytes, reducing proteinuria by repairing cytoskeletal damage.
Drying morphine sulfate methanolic solvate in water vapor replaces methanol molecules, reducing genotoxic ABUK impurities below 25 ppm.
A 5'-hydroxy-5-nitro-indirubin-3'-oxime compound selectively inhibits cyclin-dependent kinases to arrest cancer cell cycles.
Segmenting film production into independent layers bonded by a water-soluble adhesive reduces drying time and prevents active ingredient stress.
Benzyl alcohol preserves oral melatonin solutions against microbial contamination while sodium ascorbate prevents oxidation, ensuring patient compliance.
Compounds form covalent bonds with cysteine residues to lock the switch II region into an inactive conformation.
Dimebolins modulate glutamate receptors and inhibit calcium channels to reduce seizure frequency while minimizing adverse effects.
Replacing sodium with meglumine prevents lyophilized mass formation, resolving the solubility-dissolution time contradiction.
Topical diacerein formulations bypass gastrointestinal metabolism to treat systemic conditions while avoiding laxative side effects.
A 6-chloro phenoxychroman carboxylic acid derivative acts as a specific DP2 receptor antagonist to inhibit allergic responses.
PEG-lipid nanoparticles encapsulate hydrophobic retinoids, bypassing efflux carriers and solubility limits to treat neurodegenerative diseases.
Combining adrenergic compounds with steroids reduces side effects and rebound congestion while maintaining effective nasal passage patency.
A benzoylamino acetic acid derivative resists tumor cell migration and invasion with low cytotoxicity.
An aromatic compound designed for estrogen receptor degradation.
GC-1 sobetirome accelerates hepatocyte proliferation to prevent post-hepatectomy liver failure and improve graft survival rates.
Synthetic compounds modulate intracellular NAD levels to protect healthy cells and target unhealthy tissues.
Myriocin nanocarriers inhibit de novo ceramide synthesis to reduce infarct size and improve cardiac contractility.
Chiral resolution isolates active enantiomers to reduce hypersensitivity and drug resistance in cardiac treatments.
Novel 2-oxo-5H-chromeno[4,3-b]pyridine compounds target viral replication and cccDNA production.
Phytoecdysones reduce lipid deposition while preserving muscle strength during low-calorie diets.
Aziridine prodrugs activate selectively in hypoxic tumor environments, reducing cancer cell viability while sparing normal tissues from damage.
Cell-penetrating peptides deliver CRISPR RNA to selectively cleave target bacterial DNA sequences.
RARβ agonists activate nuclear receptors to reduce oxidative stress and mast cell degranulation, preventing reperfusion injury and arrhythmias.
Recombinant adeno-associated viruses deliver short hairpin RNAs to target mutant SOD1 polynucleotides.
Injectable thermosensitive hydrogels deliver antibiotics to infected spinal sites via in situ gelation.
A nanoparticle vector enables targeted RNA self-delivery through host-guest interactions between cyclodextrin and adamantane ligands.
Simplified pyrano[2,3-c]xanthene compounds provide selective OSBP inhibition and stability while avoiding complex synthesis routes.
Calcium electroporation induces tumor necrosis via calcium overload, overcoming apoptosis resistance in cancer treatment.
Segmented gastro-resistant microspheres ensure homogeneous drug release in the colon, resolving incomplete distribution from conventional tablets.
Small molecule linkers couple cytotoxins to affibodies, creating nanoparticles that reduce systemic toxicity while maintaining high cytotoxicity at tumor sites.
Targeting alpha3 subunits avoids alpha1 activation, eliminating sedation and cognitive impairment while treating neuropathic pain.
Lactic acid bacterium exopolysaccharides increase CCR6-positive CD8+ T lymphocyte populations to improve cancer treatment efficacy.
Topical pea protein and polysaccharide combination restores skin barrier function by reducing tight junction alterations.
Chromenone inhibitors bind peripheral pockets on mutant PI3Kα, sparing wild-type enzyme activity and reducing metabolic toxicity.
Melatonin agonists modulate T cell balance to reduce seasonal worsening of multiple sclerosis by adjusting treatment based on circadian rhythms.
Maleate salt crystalline forms of Compound 1 resolve poor oral absorption by enhancing solubility and stability.
Liposome composition shifts gel to liquid phase at 39°C to 45°C, releasing therapeutic agents at heated target sites.
Bioreducible lipid nanoparticles encapsulate CRISPR mRNA and sgRNA for targeted genome editing.
Optimized compounds counteract raltegravir resistance by binding conserved integrase residues for high therapeutic selectivity.
Bromodomain inhibitors target host cell proteins to suppress viral replication, addressing limited efficacy of existing antiviral agents.
Segmented oxycodone matrices deliver immediate relief followed by 24-hour analgesia, reducing administration frequency from multiple daily doses to once daily.
A multicomponent pharmaceutical formulation restores erythrocyte function and oxygen delivery to the brain.
Thermal assembly of AS1411 aptamers with tetrahedral DNA nanostructures protects nucleic acid drugs from lysosomal degradation.
EphA4 inhibitors block receptor-ligand interactions to reverse synaptic impairments caused by overactive signaling.
A tooth-matching oral retention device secures a coated tablet core in the mouth to enable stable drug release.
Indazole derivatives antagonize glucagon receptors, reducing hepatic glucose output and improving insulin sensitivity for Type II diabetes treatment.
A hydroxymethylfurfural derivative obtained by heat-treating asparagus with hot water induces HSP70 expression.
Segmenting the molecule into distinct functional regions resolves the trade-off between targeted RNA cleavage and stability against exonuclease degradation.
Oleoyl glycerol complex solubilizes taxane in a stable liquid solution at room temperature, preventing precipitation and boosting oral bioavailability.
Tirasemtiv targets the troponin-tropomyosin complex to enhance calcium sensitivity, reducing slow vital capacity decline in ALS patients.
Quinazolinedione derivatives inhibit phosphodiesterase 7 and 8, increasing cAMP and cGMP levels to treat cardiovascular diseases.
A topical composition using indirubin derivatives and plant extracts to promote hair growth.
Heterogeneous sulfation patterns in HS16 resolve contradictions between thermal stability and signaling efficacy for tissue repair applications.
A single fluorescent protein detects autophagy activity through pH-dependent fluorescence changes in acidic and neutral cellular environments.
A pressurized aerosol nasal spray device delivers metered pharmaceutical doses through a specialized actuator and metering valve assembly.
Administering an opioid antagonist that selectively enters the fetal brain prevents neonatal abstinence syndrome without causing maternal withdrawal.
N-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives combine 5-HT1A agonism with serotonin reuptake inhibition.
Pump-controlled heparin boluses adapt to blood volume and cardiac output, preventing membrane loss during dialysis priming.
Substituted quinazolines block ERK kinase activity via local quality design, reducing off-target side effects while treating hyperproliferative disorders.
Amphiphilic carbohydrate polymers self-assemble into hierarchically organized micellar clusters that transform into stable nanoparticles.
Topical detomidine treats pruritus by inhibiting peripheral signal transduction, avoiding systemic side effects of oral drugs.
Formula Ia compounds stabilize the 5-HT2A receptor, treating psychiatric disorders without dopamine D2 interference.
Carboxy-terminated branched polylactides resolve stability and entrapment trade-offs to solubilize poorly water-soluble drugs.
A crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid with controlled molar ratios.
Ferrostatins prevent iron-dependent lipid peroxidation, resolving the contradiction between selective tumor destruction and normal cell preservation.
Patsnap Eureka TRIZ case: Acetone-induced precipitation yields LASAG particles under 40 microns with high yield, eliminating seed crystal contamination risks.
Heterocyclic compounds induce ubiquitination and proteasomal degradation of estrogen receptors to overcome acquired resistance in metastatic breast cancer.
A naphthalene diamide compound inhibits tumor cell growth through electrical interactions and aromatic stacking with biological targets.
Small molecule RORγ modulators bind to the orphan nuclear receptor to regulate transcriptional activity.
Selective triazolopyridyl compounds inhibit CYP11B2 to lower aldosterone while preserving cortisol production, avoiding receptor antagonist side effects.
Formula I compounds inhibit PTPN2 and PTPN1 via selective binding to reduce off-target effects while enhancing cancer immunotherapy efficacy.
Secoisolariciresinol diglucoside activates the Nrf2 pathway to reduce oxidative stress and airway hyperreactivity in steroid-resistant asthma.
A bifractional excipient dry powder formulation uses porous coarse carriers and fine dispersants to enhance aerosolization of medicament particles.
N-acyl triazolopyrazine compounds act as selective NK-3 receptor antagonists, resolving safety and metabolic stability trade-offs through parameter changes.
Macrocyclic compounds inhibit ALK and ROS1 kinases with enhanced enzymatic potency, overcoming treatment resistance in non-small cell lung cancer.
Irreversible proteasome inhibitor marizomib crosses the blood-brain barrier to deliver therapeutic concentrations directly to central nervous system tissues.
5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine blocks adenosine signaling to restore immune surveillance.
A cascade reaction between 2-nitrobenzofuran and 5H-thiazolone constructs 1,4-sulfur-bridged polycyclic compounds with four consecutive chiral centers.
An amphiphilic matrix solubilizes gimatecan via micelle formation, resolving water solubility limits.
Antagonists suppress Latexin-mediated apoptosis in hematopoietic stem cells, accelerating blood cell recovery after chemotherapy exposure.
A fusion mixture containing specific amphipathic and aromatic molecules forms fusogenic liposomes that transfer charged molecules into lipid membranes.
Selective Nav1.7 blockers deliver potent pain relief while avoiding central nervous system disturbances linked to non-specific inhibitors.
Topical CRISPR-modified bacteria reduce infection severity by restoring immune robustness and displacing pathogens.